SCHEMBL2974180

SCHEMBL2974180

CC(O)c1cc(Cl)cc(Cl)c1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.56
GABRB1 P18505 1/20 0.56
ALDH1A1 P00352 5/20 0.54
HSD17B10 Q99714 4/20 0.54
TSHR P16473 3/20 0.54
CYP3A4 P08684 2/20 0.54
RECQL P46063 2/20 0.54
LMNA P02545 4/20 0.43
MAPT P10636 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
HPGD P15428 2/20 0.43
ALOX15 P16050 2/20 0.43
ALOX12 P18054 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
HIF1A Q16665 2/20 0.43
TTR P02766 2/20 0.43
HTT P42858 2/20 0.43
KDM4E B2RXH2 1/20 0.43
SLC22A2 O15244 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11340181 0.89 GABRA1 (0.70) GABRA1GABRB1ALDH1A1HSD17B10TSHR
SCHEMBL12767956 0.84 GABRA1 (0.78) GABRA1GABRB1ALDH1A1HSD17B10TSHR
SCHEMBL9812436 0.81 HSD17B10 (0.46) GABRA1GABRB1ALDH1A1HSD17B10TSHR
SCHEMBL2978694 0.79 GABRA1 (0.52) GABRA1GABRB1ALDH1A1HSD17B10TSHR
SCHEMBL9797399 0.78 GABRA1 (0.50) GABRA1GABRB1ALDH1A1HSD17B10TSHR
SCHEMBL4354075 0.75 IDO1 (0.46) ALDH1A1LMNAMAPTMEN1KMT2A
SCHEMBL2421445 0.74 TSHR (0.46) GABRA1GABRB1ALDH1A1HSD17B10TSHR
Methyl Alcohol SCHEMBL28184301 0.73 HSD17B10 (0.88) GABRA1GABRB1ALDH1A1HSD17B10TSHR
SCHEMBL8872103 0.72 HSD17B10 (1.00) ALDH1A1HSD17B10TSHRCYP3A4RECQL
SCHEMBL184648 0.72 HSD17B10 (1.00) ALDH1A1HSD17B10TSHRCYP3A4RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090074691-A1 Topical Delivery System for Antiaging and Skin Whitening Agents BIODERM RESEARCH (US) 2009-03-19 US claimed
US-7777073-B2 Topical delivery system for antiaging and skin whitening agents BIODERM RESEARCH (US) 2010-08-17 US disclosed
US-20090074691-A1 Topical Delivery System for Antiaging and Skin Whitening Agents BIODERM RESEARCH (US) 2009-03-19 US disclosed
US-4282390-A PARASITICIDES ICI AUSTRALIA LIMITED (AU) 1981-08-04 US disclosed
US-4163801-A PARASITICIDES, NEMATOCIDES ICI AUSTRALIA LIMITED (AU) 1979-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090074691-A1 Topical Delivery System for Antiaging and Skin Whitening Agents TYR, MMP17, MMP1 GABRA1 4083/4885GABRB1 3312/4885ALDH1A1 567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.